Skip to main content
OpenTrials

Clinical trial condition

Advanced Solid Tumors

Explore clinical trials studying Advanced Solid Tumors. Study availability and eligibility vary by location and protocol.

631 public trials 195 recruiting studies
Refine in advanced search Browse all conditions

Advanced Solid Tumors trial results

Recruiting

A Study to Assess Safety, Tolerability and Drug Levels of Navlimetostat (BMS-986504) in Participants With Advanced Solid Tumors

NCT07077434

Conditions
Advanced Solid Tumors
Locations
  • Beijing Cancer hospital Beijing, Beijing Municipality, China
  • Fujian Cancer Hospital Fuzhou, Fujian, China
  • Guangdong Provincial People's Hospital Guangzhou, Guangdong, China
  • Peking University Shenzhen Hospital Shenzhen, Guangdong, China
View Trial Details
Recruiting

Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors

NCT06040541

Conditions
Advanced Solid Tumors, Bronchial Neoplasms, Carcinoma, Bronchogenic, +29 more
Locations
  • University of California, Davis Comprehensive Cancer Center Sacramento, California, United States
  • Smilow Cancer Hospital (Yale University) New Haven, Connecticut, United States
  • Florida Cancer Specialists Sarasota, Florida, United States
  • Lee Moffitt Cancer Center Tampa, Florida, United States
View all 17 locations
View Trial Details
Recruiting

A Phase 1/1B Study of ST-01156, a Small Molecule RBM39 Degrader, in Patients With Advanced Solid Malignancies

NCT07197554

Conditions
Adenocarcinoma, Advanced Solid Tumors, Biliary Tract Cancer (BTC), +30 more
Locations
  • The City of Hope National Medical Center Duarte, California, United States
  • Hoag Memorial Hospital Newport Beach, California, United States
  • Mass General Brigham Cancer Institute Boston, Massachusetts, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details
Recruiting

A TRIAL TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS, AND EFFICACY OF SHR-A1904 IN SUBJECTS WITH ADVANCED SOLID TUMORS

NCT05277168

Conditions
Advanced Solid Tumors
Locations
  • Mount Sinai Comprehensive Cancer Center Miami Beach, Florida, United States
  • Comprehensive Hematology Oncology St. Petersburg, Florida, United States
  • LSU Health Sciences Center New Orleans, Louisiana, United States
  • University Hospitals Cleveland Medical Center Cleveland, Ohio, United States
View all 28 locations
View Trial Details
Recruiting

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), and Antitumor Activity of ALK201 in Participants With Advanced Solid Tumors

NCT06656390

Conditions
Advanced Cancer, Advanced Solid Tumors
Locations
  • Denver Drug Development Unit Denver, Colorado, United States
  • UCF Lake Nona Cancer Center Orlando, Florida, United States
  • University Medical Center New Orleans New Orleans, Louisiana, United States
  • Sarah Cannon Research Institute Oncology Partners Nashville, Tennessee, United States
View all 38 locations
View Trial Details
Recruiting

AMT-676 in Patients With Advanced Solid Tumors

NCT06400485

Conditions
Advanced Solid Tumors
Locations
  • Carolina Biooncology Institute Huntersville, North Carolina, American Samoa
  • John Hopkins Sidney Kimmel Comprehensive Cancer Center Philadelphia, Pennsylvania, American Samoa
  • South Texas Accelerated Research Therapeutics (start) San Antonio San Antonio, Texas, American Samoa
  • SCIENTIA Clinical Research Ltd Randwick, New South Wales, Australia
View all 13 locations
View Trial Details
Recruiting

Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS

NCT05379985

Conditions
Adenocarcinoma, Advanced Solid Tumors, Bronchial Neoplasms, +45 more
Locations
  • UC Irvine/Chao Family Comprehensive Cancer Center Orange, California, United States
  • UCLA Santa Monica, California, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • Piedmont Healthcare Atlanta, Georgia, United States
View all 21 locations
View Trial Details

Related conditions